Qiagen Registers QIAsymphony Sample Prep Module with Chinese SFDA | GenomeWeb

Qiagen said today that it has registered its QIAsymphony SP instrument with China's State Food and Drug Administration.

The QIAsymphony SP fully automates assay sample preparation, and can handle an extensive variety of starting materials such as blood and tissue samples, with a wide range of input and output volumes and formats, Qiagen said.

The company added that more than 40 protocols to isolate, purify, and prepare DNA, RNA, and proteins have been optimized for use on the SP instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.